Kenneth S. Fellows | The Westfield News |February 19, 2024
WESTFIELD - Kenneth S. Fellows of Westfield, Massachusetts passed away at his home surrounded by his family in the early hours of Friday, February 16th,
Source: thewestfieldnews.com
📰 David Fellows News
David Fellows News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from David Fellows. Real-time updates on events, politics, business and more.
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
Proven Industry Executive Brings More Than 25 Years of Leadership ExperienceFOSTER CITY, Calif., Feb. 07, 2024 -- Terns Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company...
Amy Burroughs Crinetics Pharmaceuticals Egon Zehnder International Dartmouth College Berry Company Public Relations Procter Gamble
Source: marketscreener.com
Join Boulder JCC's Men of the J as They Celebrate One Year! – Boulder Jewish News
Join the Men of the J in celebration to mark the one-year anniversary at the Boulder JCC on Thursday, January 25 for dinner and a beer tasting from local company Wibby Brewing.
Source: boulderjewishnews.org
Boulder JCC's Men of the J Celebrate One Year! – Boulder Jewish News
Join the Men of the J in celebration to mark the one-year anniversary at the Boulder JCC on Thursday, January 25 for dinner and a beer tasting from local company Wibby Brewing.
Source: boulderjewishnews.org
Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer
FOSTER CITY, Calif., Nov. 27, 2023 -- Terns Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious...
Senthil Sundaram Intercept Pharmaceuticals Inc Brown University Head Of Business Development Peritoneal Cancer Foundation Terns Pharmaceuticals Inc
Source: marketscreener.com
Oxular Announces Appointment of Mark Gaffney as Chief Executive Officer
OXFORD, United Kingdom & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oxular Limited, a clinical-stage ophthalmic company developing long-lasting targeted treatments for retinal disorders to improve patients’ vision, today announces that Mark Gaffney has been appointed as chief executive officer (CEO) and member of the Board...
United States United Kingdom Thomas Cavanagh Mark Gaffney Boston University University Of Pennsylvania
Source: pharmiweb.com
Direct drills revisited: 10m Dale Eco XL
This year marked a decade of Dale drills at Whiting Ash Farms in Malvern, Worcestershire, and David Fellows sees no prospect of that changing in the
Source: fwi.co.uk
Terns Pharmaceuticals Announces Leadership Transition
FOSTER CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to
Mark Vignola Senthil Sundaram Company Nasdaq Head Of Research Development At Terns Terns Pharmaceuticals Inc Head Of Research Development
Source: eagletribune.com
Terns Pharmaceuticals Announces Leadership Transition
Senthil Sundaram Stepping Down as Chief Executive Officer for Health Reasons...
Senthil Sundaram Mark Vignola Head Of Research Development Head Of Research Development At Terns Berry Company Public Relations Peritoneal Cancer Foundation
Source: globenewswire.com
Syncona : Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness
New leading gene therapy company created combining late-stage X-linked retinitis pigmentosa program from AGTC, a preclinical program spun out from the University of Oxford and a second... | June 12, 2023
Source: marketscreener.com